The Evil Twin of the LDL (Bad) Cholesterol

January 30, 2022

Lipoprotein (a), or Lp(a), pronounced “LP little a”

Lp(a) has been referred to as the evil twin of the more familiar LDL (bad) cholesterol.

It consists of an LDL-like particle with an extra protein coil that makes the particle more sticky to burrow into and damage the arterial wall.

Lp(a) is a triple threat because it is:

  • Pro-atherogenic causing a higher risk of producing plaque in arteries
  • Pro-thrombotic meaning it promotes the formation of blood clots causing heart attacks and strokes
  • Pro-inflammatory – inflammation can irritate your blood vessels, promote the growth of plaque, loosen plaque in your arteries, and trigger blood clots1

Lp(a) is determined by your genes.  Exercise and dietary lifestyle changes have no effect on your level of Lp(a) but do contribute to your over health.

If you have experienced a heart attack or stroke before turning 60 years old, or have a family member who did, you could be at risk for elevated Lp(a).

As an ENCORE community perk, we can perform a complimentary blood draw to check your level of Lp(a).

To see a list of cutting-edge treatments for elevated Lp(a) currently enrolling in clinical trials, click the link below:

If you are interested in participating in a clinical trial for elevated Lp(a), give our recruiting office a call today! (904) 730-0166


Encore logo

As a proven clinical research organization, we take every precaution to ensure the safety of and maximize the value for our research volunteers. Qualified doctors, nurses and study coordinators on staff provide support and care throughout the research trial. Participation is always voluntary. We appreciate the time and effort that research volunteers bring to this important process.

Copyright 2023 ENCORE Research Group